242 related articles for article (PubMed ID: 18806226)
1. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers.
Dumont N; Wilson MB; Crawford YG; Reynolds PA; Sigaroudinia M; Tlsty TD
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14867-72. PubMed ID: 18806226
[TBL] [Abstract][Full Text] [Related]
2. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
3. The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition.
Tan EJ; Kahata K; Idås O; Thuault S; Heldin CH; Moustakas A
Nucleic Acids Res; 2015 Jan; 43(1):162-78. PubMed ID: 25492890
[TBL] [Abstract][Full Text] [Related]
4. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
5. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
Pistore C; Giannoni E; Colangelo T; Rizzo F; Magnani E; Muccillo L; Giurato G; Mancini M; Rizzo S; Riccardi M; Sahnane N; Del Vescovo V; Kishore K; Mandruzzato M; Macchi F; Pelizzola M; Denti MA; Furlan D; Weisz A; Colantuoni V; Chiarugi P; Bonapace IM
Oncogene; 2017 Oct; 36(40):5551-5566. PubMed ID: 28581528
[TBL] [Abstract][Full Text] [Related]
8. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
[TBL] [Abstract][Full Text] [Related]
9. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
11. Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Papageorgis P; Lambert AW; Ozturk S; Gao F; Pan H; Manne U; Alekseyev YO; Thiagalingam A; Abdolmaleky HM; Lenburg M; Thiagalingam S
Cancer Res; 2010 Feb; 70(3):968-78. PubMed ID: 20086175
[TBL] [Abstract][Full Text] [Related]
12. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
16. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
Lombaerts M; van Wezel T; Philippo K; Dierssen JW; Zimmerman RM; Oosting J; van Eijk R; Eilers PH; van de Water B; Cornelisse CJ; Cleton-Jansen AM
Br J Cancer; 2006 Mar; 94(5):661-71. PubMed ID: 16495925
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
20. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
